Navigate Fool.com
Will FOLD beat
the market?

Amicus Therapeutics, Inc. (NASDAQ: FOLD)

Community Rating: 2 Stars: Unattractive

4.45 0.19 (4.46%)

REAL-TIME: Last trade at

Extended Hours: $4.52 $0.07 (1.60%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.30
Previous Close $4.26
Daily Range $4.30 - $4.74
52-Week Range $1.77 - $4.74
Market Cap $286.3M
P/E Ratio -4.02
Dividend (Yield) $0.00 (0.0%)
Volume 3,471,613
Average Daily Volume 2,192,061
Current FY EPS -$0.94

How do you think FOLD
will perform against the market?

Top FOLD Bull/Bear Pitches


zzlangerhans (< 20)
Submitted March 29, 2014

I've sort of given up on Amicus myself after following them for seven years and not seeing any signs of success or impending success in clinical trials of their small molecule &quot;chaperones&quot; f … More

0 Replies Reply Report this Post

zzlangerhans (< 20)
Submitted December 3, 2012

Amicus is showing another upward kick in advance of data from Study 011 of Amigal in Fabry's disease, with topline results likely to be released this month. Similar upward movements earlier this year … More

4 Replies Reply Report this Post

News & Commentary Rss Feed

3 Stocks That Soared Stupendously This Week

Double-digit gains in a shortened trading week? Here's how these 3 stocks did it.

Up 20%: Time to Buy Amicus Therapeutics, Inc?

Amicus shares spiked again today. What's going on with this stock?

Why GoPro, GW Pharmaceuticals, and Amicus Therapeutics Are Today's 3 Best Stocks

The S&P 500 meanders as investors wait for earnings season to start, while GoPro, GW Pharmaceuticals, and Amicus Therapeutics all advance by double-digit percentages.

Sector Update: Healthcare Stocks Losses Accelerate This Afternoon; Amicus Rises After Completing Lat

Sector Update: Healthcare Stocks Losses Accelerate This Afternoon; Amicus Rises After Completing Late-Stage Study of Genetic Disorder Treatment

Sector Update: Healthcare

Massive Swings: Biota Pharmaceuticals, Inc. and Amicus Therapeutics, Inc.

Big moves from two tiny stocks: what is a Foolish investor to do?

Twitter gains ahead of earnings; Gogo sinks

U.S. stocks rise; Dow sees triple-digit gain

In Insider Trading, Purchases by GlaxoSmithKline and Noted Biotech Investor Randal Kirk

Top Analyst Upgrades and Downgrades: Rite Aid, Qualcomm, Facebook, ARM and More

See More FOLD News...





Amicus Therapeutics, Inc. (FOLD) Description

A clinical-stage biopharmaceutical company, which focused on the discovery, development and commercialization of novel small molecule, orally-administered drugs, known as pharmacological chaperones, for the treatment of a range of human genetic diseases. Website: http://www.amicusrx.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks